[Correlation between syndrome factor combination and cardiac function as well as blood-lipid in coronary heart

Jie Wang1, Qing-Yong He, Zhan Shi

  • 1Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.

Insights

Traditional Chinese Medicine (TCM) syndrome factor combinations in coronary heart disease (CHD) correlate with cardiac function and blood lipids. Specific TCM patterns like yang deficiency and blood stasis impact ejection fraction, while others affect lipid levels.

Area of Science:

  • Integrative Medicine
  • Cardiology
  • Traditional Chinese Medicine

Context:

  • Coronary heart disease (CHD) is a leading cause of mortality worldwide.
  • Understanding the etiological patterns within Traditional Chinese Medicine (TCM) offers insights into disease mechanisms.
  • TCM syndrome differentiation provides a framework for analyzing complex disease presentations.

Purpose:

  • To investigate the distribution and correlation of Traditional Chinese Medicine (TCM) syndrome factor combinations in patients with coronary heart disease (CHD).
  • To examine the relationship between specific TCM syndrome factor combinations and objective measures of cardiac function and blood lipid profiles in CHD patients.

Summary:

  • A study of 300 CHD patients identified key TCM syndrome factor combinations: blood stasis due to qi deficiency, qi and yin deficiency, intermingled phlegm and blood stasis, and yang deficiency and blood stasis.
  • Yang deficiency and blood stasis were associated with decreased ejection fraction.
  • Intermingled phlegm and blood stasis correlated with elevated triglyceride and low-density lipoprotein cholesterol, while qi and yin deficiency was linked to increased triglyceride levels.

Impact:

  • Findings support targeted TCM herbal medicine strategies for CHD, focusing on supplementing qi, activating blood circulation, nourishing yin, resolving phlegm, and activating yang.
  • Treatment recommendations are tailored: activating yang and blood circulation for low cardiac function, and resolving phlegm, activating blood, and replenishing qi/yin for blood-lipid disturbances.
  • This research bridges TCM diagnostics with Western medical parameters, potentially improving personalized treatment approaches for coronary heart disease.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...